Literature DB >> 18799981

Exercise testing to estimate survival in pulmonary hypertension.

Herman Groepenhoff1, Anton Vonk-Noordegraaf, Anco Boonstra, Marieke D Spreeuwenberg, Pieter E Postmus, Harm J Bogaard.   

Abstract

BACKGROUND: : The 6-min walk distance (6MWD) predicts survival in pulmonary hypertension (PH). The peak oxygen consumption (V O2peak) measured during a cardiopulmonary exercise test (CPET) also relates to survival in PH, and it is unknown how the prognostic information from measurements of ventilatory responses and gas exchange during CPET compares to the prognostic information obtained by the 6MWD alone. The aims of our study were to compare prognostic values of different exercise parameters in PH and to assess whether CPET adds prognostic value to the information from the 6MWD.
METHODS: : After baseline right-heart catheterization and exercise testing, survival was assessed in a cohort of 115 PH patients.
RESULTS: : During the 4 yr of follow-up, 18 patients died. At baseline, pulmonary arterial pressure was 49 +/- 17 mm Hg, the slope relating minute ventilation to carbon dioxide output (V E/V CO2slope) = 45 +/- 11, V O2peak = 15 +/- 6 mL.kg.min, increase in O2 pulse from rest to peak exercise (DeltaO2 pulse) = 5 +/- 2 mL.beat, and 6MWD = 445 +/- 128 m. For the prediction of mortality, the areas under the receiver operating curves were very similar for the different parameters and ranged from 0.69 to 0.74. Patients with a V E/V CO2slope < 48, V O2peak > 13.2 mL.kg.min, DeltaO2 pulse > 3.3 mL.beat, or a 6MWD > 399 m had a higher cumulative survival (P < 0.05). Multivariable Cox regression with a forward selection procedure showed that only DeltaO2 pulse improved the univariate 6MWD prediction model significantly (P < 0.05).
CONCLUSION: : CPET parameters predict survival in PH patients and add marginally to the prognostic value of the 6MWD.

Entities:  

Mesh:

Year:  2008        PMID: 18799981     DOI: 10.1249/MSS.0b013e31817c92c0

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  36 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 2.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

Review 3.  [Diagnostics in pulmonary hypertension].

Authors:  M Leschke; A Wädlich; S Waldenmaier; M Faehling
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

4.  Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension.

Authors:  Ronald J Oudiz; Raghu Midde; Arsen Hovenesyan; Xing-Guo Sun; Giorgio Roveran; James E Hansen; Karlman Wasserman
Journal:  Am J Cardiol       Date:  2010-04-15       Impact factor: 2.778

5.  Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.

Authors:  Hilary F Armstrong; P Christian Schulze; Matthew Bacchetta; Wilawan Thirapatarapong; Matthew N Bartels
Journal:  Respirology       Date:  2014-05-06       Impact factor: 6.424

6.  Oxygen pulse kinetics in Fontan patients during treadmill ramp protocol cardiopulmonary exercise testing.

Authors:  Manish Bansal; Justin J Fiutem; James A Hill; Mary Ann O'Riordan; Kenneth G Zahka
Journal:  Pediatr Cardiol       Date:  2012-04-01       Impact factor: 1.655

7.  MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.

Authors:  Martin Kolditz; Hans-Jürgen Seyfarth; Heinrike Wilkens; Ralf Ewert; Tom Bollmann; Christiane Dinter; Sabine Hertel; Hans Klose; Christian Opitz; Ekkehard Grünig; Gert Höffken; Michael Halank
Journal:  Lung       Date:  2015-09-12       Impact factor: 2.584

8.  Right ventricular stroke work index as a negative predictor of mortality and initial hospital stay after lung transplantation.

Authors:  Hilary F Armstrong; P Christian Schulze; Tomoko S Kato; Matthew Bacchetta; Wilawan Thirapatarapong; Matthew N Bartels
Journal:  J Heart Lung Transplant       Date:  2013-04-06       Impact factor: 10.247

9.  Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension.

Authors:  Yi-Jen Chen; Hung-Pin Tu; Chia-Ling Lee; Wei-Chun Huang; Jin-Shiou Yang; Cyuan-Fong Li; Chia-Hsin Chen; Ko-Long Lin
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

10.  Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.

Authors:  Mohamad Amer Alaiti; Aditya Goud; Gautam Ramani; Sashwatee Bagchi; Sadeer Al-Kindi; Steven Sawicki; Christopher Longenecker; Trevor Jenkins; David Pauza; Myung Park; Grace McComsey; Orlando Simonetti; Brian Hoit; Sanjay Rajagopalan
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-11       Impact factor: 2.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.